Key Takeaways
- Bitcoin (BTC) surged to $120,000, reaching a seven-week high amid safe-haven demand from the ongoing U.S. government shutdown and "Uptober" seasonality, with the total crypto market cap rising to $4.16 trillion.
- European doctors recommended Novo Nordisk (NVO) and Eli Lilly (LLY) weight-loss drugs as first-line treatments for obesity, marking a significant endorsement for the pharmaceutical giants.
- President Trump announced plans for billions in aid to farmers, to be funded by tariff revenue, as producers of key exports face economic headwinds.
- The Trump administration canceled $7.56 billion in clean energy awards across 16 Democratic-led states, sparking outrage and accusations of political retaliation.
- Crude oil futures experienced a notable decline, with Brent crude falling to $64.11 per barrel and U.S. crude to $60.48 per barrel, driven by concerns over potential OPEC+ supply increases and rising U.S. inventories.
Cryptocurrency Market Sees "Uptober" Rally Amidst US Shutdown
The cryptocurrency market is experiencing a significant rally, with Bitcoin (BTC) surging to $120,000 for the first time since mid-August, setting a seven-week high. This upward momentum is largely attributed to increased safe-haven demand amid the ongoing U.S. government shutdown and the historical bullish performance typically seen in October, dubbed "Uptober" by the crypto community. The total crypto market capitalization has climbed to $4.16 trillion, a 3.5% daily gain, with Bitcoin's market cap surpassing Amazon's valuation. Smaller cryptocurrencies are also participating in the rally, with Solana (SOL) up 5.7% and Ether (ETH) climbing over 5% to $4,390. Analysts suggest a combination of macroeconomic uncertainty and favorable seasonality is fueling this rally.
Pharmaceutical Sector Boosted by Obesity Drug Recommendations
Major pharmaceutical companies Novo Nordisk (NVO) and Eli Lilly (LLY) received a significant boost as a leading European medical association, the European Association for the Study of Obesity, recommended their weight-loss drugs as first-line treatments for obesity and its complications. Novo Nordisk's Wegovy and Ozempic (semaglutide), and Eli Lilly's Zepbound and Mounjaro (tirzepatide), are considered highly effective and should be the initial choice in most cases requiring substantial weight loss. This endorsement, published in Nature Medicine, highlights the transformative impact of GLP-1 agonists on obesity care. Novo Nordisk shares were up 2.2% following the announcement.
US Policy Shifts Impact Farmers and Clean Energy
President Donald Trump announced plans to provide billions in aid for American farmers, intending to use revenue generated from tariffs to support those struggling with trade uncertainty. This initiative aims to assist producers of key exports like corn, soy, wheat, sorghum, and cotton facing difficult economic conditions. The administration anticipates that Congress will need to authorize the use of tariff revenue for this aid package, with potential payouts beginning in early 2026.
Concurrently, the Trump administration has moved to cancel $7.56 billion in clean energy awards, affecting 223 projects across 16 states. These cancellations, which include California's hydrogen hub, target states that voted against Trump in the 2024 presidential election. White House budget chief Russ Vought described the funding as "Green New Scam funding," while Democrats have denounced the move as illegal political retaliation that could harm job creation and raise energy costs.
Federal Reserve Navigates Government Shutdown Without Key Data
The ongoing U.S. government shutdown is creating challenges for the Federal Reserve, as official economic data, including the unemployment rate, is delayed. Chicago Fed President Austan Goolsbee stated that the Fed would be forced to make interest rate decisions using available real-time indicators which currently suggest a steady unemployment rate, estimated at 4.3% in September. The immediate impact of the shutdown is on federal workers who are not receiving timely pay.
Geopolitical Landscape: Nuclear Warnings and Gaza Peace Plan
Russian President Vladimir Putin issued a stark warning, stating that Russia would conduct nuclear tests if other nations do so, noting that Moscow could "theoretically revoke ratification" of the international nuclear test ban treaty. This comes amidst broader discussions on nuclear arms control, with Putin asserting that if China is included in future nuclear talks, France and Britain should also participate. Russia has also proposed a one-year extension of the New START treaty limits with the U.S., which is set to expire in 2026.
In the Middle East, a U.S. official indicated that President Trump’s 21-point Gaza plan has international support, with hopes that Hamas will approve it to allow implementation. The plan, unveiled on September 29, 2025, calls for an immediate ceasefire, hostage release, Hamas disarmament, and a transitional governance structure. Trump has given Hamas a limited timeframe to respond, warning of severe consequences if rejected.
Commodity Markets See Oil Decline, Gold Retreats from Record Highs
Brent crude futures closed at $64.11 per barrel, decreasing by $1.24, a drop of 1.9%. Similarly, U.S. crude oil futures closed at $60.48 per barrel, down $1.30 or 2.10%. This decline in oil prices, reaching four-month lows, is influenced by expectations of higher OPEC+ supply and an increase in U.S. crude stocks.
Meanwhile, gold (XAU) retreated as the dollar strengthened and investors engaged in profit-taking after a five-day rally that saw bullion reach fresh records. Despite the recent pullback, the metal has surged 46% this year, putting it on track for its biggest annual gain since 1979, supported by central-bank buying and rising ETF holdings.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.